Godrej Agrovet FY26 Revenue Surpasses ₹10,000 Crore, Profitability at All-Time High
Godrej Agrovet's FY26 consolidated revenue grew 9.1% to ₹10,233 Crore, with PAT up 13.9% to ₹445 Crore. Q4 FY26 PAT rose 54.7% to ₹102 Crore. Animal Nutrition volumes grew 11.6%, Oil Palm revenue increased 42.4%, and Astec LifeSciences showed a turnaround. Net working capital optimized to 25 days.
The announcement includes comprehensive financial results for the full year and the quarter, highlighting record profitability and substantial growth, which is material information for investors.
The company reported record profitability, significant revenue growth across key segments, and improved operational efficiencies, indicating a strong financial performance.
Godrej Agrovet Limited announced its Standalone and Consolidated Audited Financial Results for the Quarter and Financial Year ended March 31, 2026, on April 30, 2026. The company reported a robust FY26 performance, surpassing ₹10,000 Crore in revenue with all-time high profitability. Consolidated revenue from operations for FY26 stood at ₹10,233 Crore, an increase of 9.1% year-on-year. EBITDA grew by 10.8% to ₹969 Crore, and Profit Before Tax (PBT) increased by 17.2% to ₹602 Crore. Profit After Tax (PAT) rose by 13.9% to ₹445 Crore.
For the fourth quarter of FY26, consolidated revenue from operations was ₹2,333 Crore, up 9.3% year-on-year. EBITDA for Q4 FY26 increased by 8.5% to ₹207 Crore, while PBT saw a significant jump of 61.9% to ₹120 Crore. PAT for the quarter grew by 54.7% to ₹102 Crore.
The Animal Nutrition segment reported strong volume growth of 11.6% for FY26, with volumes growing 18% year-on-year in cattle feed. The Oil Palm business achieved double-digit volume growth and strong revenue growth of 42.4% to ₹1,908 Crore, with segment results growing by 67.9% to ₹384 Crore. The Crop Care business was impacted by adverse weather and regulatory disruptions, with revenue at ₹772 Crore and segment results at ₹224 Crore. Astec LifeSciences demonstrated a turnaround with revenues of ₹448 Crore and EBITDA at ₹1 Crore for FY26. Creamline Dairy reported revenues of ₹1,589 Crore for FY26, with EBITDA at ₹53 Crore, impacted by elevated milk procurement prices. Godrej Foods Limited focused on branded businesses, with branded revenue salience increasing to over 80% in FY26.
The company also highlighted significant optimization of its net working capital, which reduced to 25 days in FY26 from 39 days in FY25, contributing to an improved average Return on Capital Employed (ROCE) of 20% in FY26.
What to do with a filing like this
Godrej Agrovet Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Godrej Agrovet Limited. Read the original for the full detail.